In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.
Turan
Hale
H
Arslan
Hande
H
Azap
Ozlem Kurt
OK
Serefhanoğlu
Kivanç
K
Uncu
Hikmet
H
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002002:Brucella / Q000187:drug effects* / Q000302:isolation & purification; D002006:Brucellosis / Q000097:blood / Q000188:drug therapy / Q000382:microbiology; D002939:Ciprofloxacin / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D004318:Doxycycline / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D012293:Rifampin / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D000078304:Tigecycline
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D000078304:Tigecycline; D008911:Minocycline; D004318:Doxycycline; D012293:Rifampin